Company Profiles

driven by the PitchBook Platform

Kereos

Description

Developer of targeted molecular imaging agents and therapeutics to detect and treat cancer and cardiovascular disease. The company offers KI-0001, a magnetic resonance imaging (MRI) agent for tumor detection that finds tumors and highlights growing regions in the tumor margin.

1999

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$1.12M

Latest Deal Amount

$30.8M

Total Amount Raised

Description

Developer of targeted molecular imaging agents and therapeutics to detect and treat cancer and cardiovascular disease. The company offers KI-0001, a magnetic resonance imaging (MRI) agent for tumor detection that finds tumors and highlights growing regions in the tumor margin.

Website:

www.kereos.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

4041 Forest Park Avenue St. Louis, MO 63108United States +1 (314) 633-1879
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Kereos's full profile, request a free trial.

Kereos Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Kereos Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Kereos Investors (14)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advantage Capital PartnersVenture CapitalMinority000 0000000 0000
Alafi CapitalVenture CapitalMinority000 0000000 0000
Apjohn VenturesVenture CapitalMinority000 0000000 0000
Brooke Private Equity AssociatesFund of FundsMinority000 0000000 0000
Charter Life SciencesVenture CapitalMinority000 0000000 0000
Advantage Capital Partners Venture Capital
Alafi Capital Venture Capital
Apjohn Ventures Venture Capital
Brooke Private Equity Associates Fund of Funds
Charter Life Sciences Venture Capital

Kereos Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Phillip BucklerChief Operating Officer
Gregory Lanza Ph.DCo-Founder & Chief Scientific Officer
Phillip Buckler Chief Operating Officer
Gregory Lanza Ph.D Co-Founder & Chief Scientific Officer

Kereos Board Members (5)

NameRepresentingRoleSinceContact
Info
Fred Schwarzer JDCharter Life SciencesManaging Partner000 0000
Gary StevensonMB Venture PartnersCo-Founder & Managing Partner000 0000
John Rice Ph.DTriathlon Medical VenturesCo-Founder & Managing Partner000 0000
Michael Loberg Ph.DSelfBoard Member000 0000
Samuel Wickline MDSelfBoard Member000 0000
Fred Schwarzer JD Managing Partner Charter Life Sciences
Gary Stevenson Co-Founder & Managing Partner MB Venture Partners
John Rice Ph.D Co-Founder & Managing Partner Triathlon Medical Ventures
Michael Loberg Ph.D Board Member Self
Samuel Wickline MD Board Member Self
Request full access to PitchBook